Form 4: Humana Director David T. Feinberg Reports Stock Unit Transactions

Director David T. Feinberg reports acquisition of Humana stock units through deferred fees and dividend reinvestment.

Summary

• David T. Feinberg, a director at Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The report indicates the acquisition of additional restricted stock units (RSUs) through director's fees elected to be converted into stock units and dividend payments reinvested into stock units.
• On March 31, 2025, Feinberg acquired 66 restricted stock units at a price of $263.875.
• These stock units are deferred and will be payable in Humana Inc. common stock on a 1-for-1 basis upon his resignation as a director.
• Feinberg also holds 441 shares of Humana common stock directly and 1,593 restricted stock units from annual director's fees.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock unit transactions by a director. There's no indication of positive or negative sentiment towards the company's performance.

Positives

• The director's decision to convert fees and reinvest dividends into stock units could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance. It only details the director's transactions in Humana stock units.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the actions of company directors and their investment decisions.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by providing insight into the director's investment decisions.

Key Dates

Keywords

Form 4, Humana, Director, Stock Units, David T. Feinberg, Beneficial Ownership, RSU, Dividend Reinvestment